DUBLIN--(BUSINESS WIRE)--Sep 30, 2022--
The "Radiation Oncology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global radiation oncology market reached a value of US$ 6.97 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 10.88 Billion by 2027, exhibiting a CAGR of 7.7% during 2021-2027.
Companies Mentioned
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Radiation oncology, also known as radiotherapy, is a cancer treatment that relies on high doses of radiation to kill cancer cells and shrink tumors. It is considered a localized treatment as it affects only the part of the body being treated and damages cancer cells without harming healthy cells. It can be delivered via machines called linear accelerators or through radioactive sources placed inside the patient on a temporary or permanent basis.
The increasing risk of developing cancer on account of tobacco and alcohol consumption, unhealthy diet and physical inactivity among individuals represents one of the key factors bolstering the growth of the market. Besides this, there is a rise in the adoption of radio oncology, which includes external beam radiation therapy, to treat breast, colorectal, esophageal, head, neck, lung, and prostate cancer.
It also comprises radioactive iodine therapy (I-131), which can cure a few thyroid cancers, and targeted radionuclide therapy that helps treat advanced prostate cancer or gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Moreover, palliative radiation aids in relieving difficulties like pain, trouble swallowing or breathing, or bowel blockages caused by advanced cancer. This, coupled with the rapid expansion of cancer research centers around the world, is positively influencing the market.
Furthermore, key players are focusing on motion tracking, real-time imaging and advancements from 2D to 3D conformal radiotherapy. They are also integrating artificial intelligence (AI) to improve the accuracy, precision, efficiency, and overall effectiveness of radiation oncology. This, in confluence with the increasing investments in research and development (R&D) activities by governments of numerous countries, is projected to fuel the growth of the market in the coming years.
Key Questions Answered in This Report:
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Radiation Oncology Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
7 Market Breakup by Technology
8 Market Breakup by Application
9 Market Breakup by End User
10 Market Breakup by Region
11 SWOT Analysis
12 Value Chain Analysis
13 Porters Five Forces Analysis
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
For more information about this report visit https://www.researchandmarkets.com/r/1k62cj
View source version on businesswire.com:https://www.businesswire.com/news/home/20220930005306/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/30/2022 08:06 AM/DISC: 09/30/2022 08:06 AM
http://www.businesswire.com/news/home/20220930005306/en